SAN FRANCISCO, May 18, 2023 /PRNewswire/ — The global women’s health market size is expected to reach USD 63.02 billion by 2030, registering a CAGR of 5.4% from 2023 to 2030, according to a new report by Grand View Research, Inc. The introduction of innovative novel products and the presence of a strong pipeline of women’s … Read more
HSINCHU, May 18, 2023 /PRNewswire/ — Smart manufacturing & stringent process control enhance TPU quality. ICP DAS – BMP (Biomedical Polymers), a Taiwan-based supplier of medical-grade TPU (thermoplastic polyurethane), acts as a front-runner who deploys IIoT systems in a smart factory to maintain lot-to-lot consistency in TPU production. The company will showcase its prime quality … Read more
SHANGHAI, May 18, 2023 /PRNewswire/ — Asieris Pharmaceuticals (688176), a global biopharma company specializing in discovering, developing and commercializing innovative drugs for the treatment of genitourinary tumors and other related diseases, announced a strategic collaboration with UroViu Corporation (“UroViu”). Asieris Pharmaceuticals will obtain exclusive global rights to UroViu’s patented technology of portable single-use cystoscope in … Read more
Shared activity, inspiration, and community for millions of members across two of the world’s most engaged movement ecosystems SAN FRANCISCO, May 18, 2023 /PRNewswire/ — Strava, the subscription platform at the center of connected fitness, today announced a partnership with Nike that will, for the first time, give members the ability to track and share … Read more
IAB56 RPT agent is designed to target integrin αvβ6, a receptor over-expressed in a broad range of solid cancers underserved by current cancer therapies. IAB57 RPT agent is designed to target DLL3, a target over-expressed in cancer tissues and relevant in several cancers, most notably Small-Cell Lung Cancer (SCLC) LOS ANGELES, May 18, 2023 /PRNewswire/ … Read more
IAB56 RPT agent is designed to target integrin αvβ6, a receptor over-expressed in a broad range of solid cancers underserved by current cancer therapies. IAB57 RPT agent is designed to target DLL3, a target over-expressed in cancer tissues and relevant in several cancers, most notably Small-Cell Lung Cancer (SCLC) LOS ANGELES, May 18, 2023 /PRNewswire/ … Read more
PROVIDENCE, R.I., 18. Mai 2023 /PRNewswire/ — EpiVax, Inc. (“EpiVax”) feiert seinen 25sten Geburtstag, indem das Unternehmen sein Engagement für die Verbesserung der menschlichen Gesundheit überall auf der Welt erneuert und gleichzeitig die Entwicklung bahnbrechender Instrumente durch das Unternehmen hervorhebt. Darüber hinaus würdigt EpiVax die Arbeit von zwei gemeinnützigen Organisationen, die in diesen 25 Jahren … Read more
Recommendation will enable eligible patients in England, Wales and Northern Ireland to access the first licensed treatment for moderate-to-severe chronic kidney disease (CKD)-associated pruritus in adult patients on haemodialysis ST. GALLEN, Switzerland and STAMFORD, Conn., May 18, 2023 /PRNewswire/ — Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and Cara Therapeutics, Inc. (Nasdaq: CARA) today announced that … Read more
Recommendation will enable eligible patients in England, Wales and Northern Ireland to access the first licensed treatment for moderate-to-severe chronic kidney disease (CKD)-associated pruritus in adult patients on haemodialysis ST. GALLEN, Switzerland and STAMFORD, Conn., May 18, 2023 /PRNewswire/ — Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and Cara Therapeutics, Inc. (Nasdaq: CARA) today announced that … Read more
New simulations from Transfr will be used by schools, workforce organizations and employers to create pathways to high-growth careers in healthcare NEW YORK, May 18, 2023 /PRNewswire/ — Thousands of aspiring health professionals nationwide will be able to train for careers in health care using virtual reality simulations, thanks to a new Virtual Healthcare Clinic … Read more